FULLY INSURED GROUPs | Rx

IBX and Sempre Health surpass $1.1 million in member savings

Our partnership with Sempre Health continues to deliver meaningful value for members, saving fully insured commercial members more than $1.1 million on prescription drugs since 2022.

Read the full press release.

ALL SEGMENTS | Rx

Rx Pipeline and New Approval Insights Report — Q3 2026

The Q3 2026 Rx Pipeline and New Approval Insights Report highlights three drugs. These drugs are seeking approval from the U.S. Food and Drug Administration (FDA) or were recently FDA approved to treat severe hypertriglyceridemia (an excess of triglycerides in the blood), narcolepsy, and dermatomyositis, a rare autoimmune disease.

Full Article